Derek S Chew

Quality of Life Outcomes with a Risk-Based Precision Testing Strategy Versus Usual Testing in Stable Patients with Suspected Coronary Disease: Results from the PRECISE Randomized Trial @GreggWStone @bchowmd @jweirmccall @derek_c1 @MichaelGNanna @DanMarkMD ahajrnls.org/3Ell68Q

Economic Outcomes with Precision Diagnostic Testing Versus Usual Testing in Stable Chest Pain: Results from the PRECISE Randomized Trial @ncurzen @derek_c1 @MichaelGNanna @DanMarkMD #AHAJournals ahajrnls.org/4hGtrlU

Semaglutide (#Ozempic, Wegovy) can help non-diabetic overweight or obese individuals with #heartdisease and be cost-effective, an article in the Canadian Journal of Cardiology shows spkl.io/6010f5dZC #weightloss @CJCJournals @SCC_CCS @Els_Cardiology @derek_c1 @obrien_iph

Viewpoint by Derek Chew, @EmilyZeitler, & @DanMarkMD: While extended ECG monitoring technologies are increasingly detecting subclinical atrial fibrillation (SCAF), the benefits of anticoagulation therapy for this population remain uncertain. ja.ma/3Z7Uwbn

Implantable Cardioverter Defibrillators for Primary Prevention During or Early Following Hospitalization? A Time to Pause, Reflect and Exercise Sound Clinical Judgement. heartrhythmjournal.com/article/S1547-…

Consumer Wearables: Advancing Atrial Fibrillation Care or Too Much Information? jamanetwork.com/journals/jamai… via @derek_c1 et al @drjohnm @AndrewFoy82 @sib313

🎉 Congrats Dr. Robert Miller, MD, named one of @AvenueCalgary's Top 40 Under 40! The professor and cardiologist is using AI to improve cardiac patient care through more accurate and efficient diagnoses. Read about his important work: bit.ly/3YDoEdh @LibinInstitute

Combining gated SPECT & vectorcardiography to guide LV lead placement to improve response to CRT. #CRT #SPECT #mechanicaldyssynchrony #electricaldyssynchrony #Vectorcardiography​ @mtu_computing @ICC_MTU @LabMiil. Read now👉bit.ly/4heeEQ6 Editorial by @derek_c1 @robertjhmiller @UCalgary

Fine-tuning early rhythm control strategies for atrial fibrillation – Timing matters to stay in sync @Derek_c1 heartrhythmjournal.com/article/S1547-…

Fine-tuning early rhythm control strategies for atrial fibrillation – Timing matters to stay in sync @Derek_c1 heartrhythmjournal.com/article/S1547-…

Enjoyed celebrating my nomination for Women of Impact at the Triangle Go Red for Heart Evening in Red! We raised awareness and funding for AHA focusing on Women’s heart health. #aha #GoRed @DukeHeartCenter @manesh_patelMD @JonPicciniSr @KLThomasMD

Dr. Robert Miller leads AI research revolutionizing CAD diagnosis. His software guides precise testing, saving lives & resources. Supported by Alberta Innovates, this breakthrough promises to address a tangible clinical need. Full story: ucalgary.ca/news/innovativ… #coronaryarterydisease #heartdisease #heathcareinnovation #precisionmedicine #ArtificialIntelligence

Dr. Steve Wilton, a distinguished Cardiac Electrophysiologist and Associate Professor @UCalgary, embodies excellence in #patientexperience. This #PXWeek, we celebrate and thank @SBWilton for his dedication to his #patients and their loved ones. Read the full article here: canetinc.ca/patient-experi… #CANetPXWeek #PWLE #IMPX #cardiology #PatientCare

I'm excited to announce our Alberta Innovates grant which will leverage artificial intelligence to support physician decision-making. We are still looking for Master's student candidates - message me Our work is growing AI expertise in Alberta. @LibinInstitute @ABInnovates

Congrats to Dr. Dean Traboulsi, who received the 2023 Outstanding Achievement Award from the Canadian Association of Interventional Cardiologists. Traboulsi helped revolutionize post heart attack care in Alberta and beyond ➡️news.ucalgary.ca/news/clinician…

@derek_c1 eloquently shares data on resource use and cost comparisons in the #PRECISE trial @ #AHA.23 🗝️ points 👇

Time to extraction matters #EPeeps Lead Extraction and Mortality Among Patients With Cardiac Implanted Electronic Device Infection jamanetwork.com/journals/jamac…

#Carvedilol vs. #Metoprolol and Risk of Arrhythmias Among #ICD Recipients In this study pooling primary prevention ICD recipients from five trials, carvedilol was associated with a 35% reduced risk of ATA and inappropriate ICD shocks compared to #metoprolol jacc.org/doi/full/10.10… @JACCJournals

#OriginalResearch In the VICTORIA trial, use of vericiguat in patients with HFrEF was associated with an increased quality-adjusted life expectancy at a cost of $66,509 per QALY @CVC_UAlberta @coconnormd @derek_c1 @DanMarkMD ahajournals.org/doi/10.1161/CI…